• Miragen Therapeutics (NASDAQ:MGEN) Lowered to “Hold” at Zacks Investment Research

    … Inc., formerly known as Signal Genetics, is headquartered in Boulder, Colorado. “ … They set a buy rating and a $3.00 target price for the company.

    Read More
  • 0 0